Soneta Cream

Psoriasis, Corticosteroid- responsive dermatoses

Topical/Cutaneous Corticosteroid-responsive dermatoses Adult: As 0.1% cream/oint: Apply a thin film to affected area once daily.

Topical/Cutaneous Corticosteroid-responsive dermatoses Child: >2 yr As 0.1% cream/oint: Apply a thin film to affected area once daily for not more than 3 wk.

The drug is contraindicated in individuals with a history of sensitivity reactions to Mometasone or any of the components of the preparation.

If irritation develops with the use of Mometasone Furoate cream, treatment should be discontinued. Lactation: use caution

C Pregnancy Category: C Lactation: use caution

Strong CYP3A4 inhibitors (e.g. ketoconazole) may increase systemic exposure of mometasone.

Burning, Pruritus, Itching, Rosacea and skin atrophy may occur.

Mometasone depresses the formation, release and activity of endogenous inflammatory chemical mediators (e.g. kinins, histamine, liposomal enzymes and prostaglandin). It inhibits the margination and subsequent cell migration to the injury site, reverses vascular dilatation and permeability, resulting in decreased access of cells to the area of injury.

Soneta 0.1% w/w Cream manufactured by Aristopharma Limited. Its generic name is Mometasone Furoate 0.1% Topical.